Member Info for MisterPositive

He touched on the Mozambique license towards the end of his recent LSE interview. Mentioned 2.3 TCF and our licence surrounding the recent huge gas discovery. Currently nothing priced in for Mozambique. Conversion: 1 TCF = 170 million barrels Mozambique might turn out to be even bigger than NOA discovery. No wonder CEO said, our current Mcap is Extremely undervalued.

Probably talking to Fund managers & Institutional investors.

Market discounts future events early and often takes the worst case scenario. Placing Or No Placing..,..market has discounted Placing anyway and dropped this back to 0.51 today from 0.65 just few days ago. Today's price makes the relative Upside even better once any uncertainty is removed. I would expect this to blow past last years 1.925p once everything is in place and news is in public domain.

Rift, That's my feel also....no placing. Hence the alternative creative finance deal worth $50m agreed with Mauritius Bank & Trafigura. Either way, we want news to come out in order to motor ahead.

Tom, Now that would be a real fire cracker... Placing & approval together. Would see this go up more than 50% on the day coz then there would be no more uncertainty. And with NNPC approval, copl can crack on with the initial 6000-10,000 bopd operation with early revenues from Crude oil exports.

Bigbench, How the devil are ya fella? Thought you gone to Mongolia to book Front row seats for the party that is coming..,

I made a suggestion to the company, it might be better to "up-list" our shares from OTC to NASDAQ in the US. US market is always much more receptive of the massive prospects than AIM.

May be MMs spooked a few to sell and grabbed stock for tomorrow Open to sell them higher. Given the very small free Float. MMs playing this very clever.

I think it's probably done already around 0.5 level... Let's just get that RNS, so we can move on with the real sexy stuff. Sooner that uncertainty is removed, sooner this can re-rate. Lot of catching up to do here in MCap terms compared to peers.

Yep, that would be tiny. Either way let's get that small Placing out of the way and this should 'Rocket' as per the heading. Multi-bags written all over it, given the extremely low MCap.

Hence the drop from 0.65 to 0.48 Should motor ahead before NNPC approval comes through.

Agree....how crazy is that.

Yep. NNPC approval expected this month as per CEO interview with LSE. FPSO - initial 6000-10,000 bopd 2 Appraisal wells to add further 5000 bopd each. Hence FDP designed for submission at 25,000 bopd. MCap is tiny....but for how long will it stay low ?

237.1 million Barrels... NOA discovery..,

If long date was 22 Aug....could we get Deal confirmation next week?

Well well well.... Oldest trick in MM books. First we could not buy any....then they dropped the Bid to spook few to sell to fill thise big orders. Got to hand it to these MMs...

To be fair each investment is different. BPC is still a speculative Buy until Deal is done. Copl has agreed $50m project finance & service agreement worth another $100m for early production scheme for upto 25000 bopd facility and FPSO. Just awaiting approval from NNPC expected this month. Funding I think is now priced in hence the drop from 0.65 to 0.49.... Need to look at relative Upside from current entry point. This goes for any share on AIM.

This would creep higher in coming days...before news. Try buying any decent Qty after RNS lands. Was impossible to buy ANY for good 5-10 minutes today morning

Agree. Time to accumulate before news. This would be going lot lot higher than just £2.00 Japanese Pharma, wants to take it all the way, with potential future sales in many Billion $$$s. I bet TAKEDA Pharma would be keeping a close eye also on trial results.

* Wholly-owned Clevegen (FP-1305) shows no toxicity in dose escalation studies in large preclinical models. * The no-observed-adverse-effect-level (NOAEL) was 100 mg/kg, which is roughly 30 times higher concentration than needed for Clever-1 occupancy in vivo. ...wow...tested at 30x higher level than needed and still no observed adverse effects. Clevegen looks like another Blockbuster on top of Traumakine.